Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022.
Saved in:
| Title: | Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022. |
|---|---|
| Authors: | Mrugala MM; Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix/Scottsdale, Arizona, USA. Mrugala.Maciej@mayo.edu., Shi W; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA., Iwomoto F; Division of Neuro-Oncology, New York-Presbyterian/Columbia University Medical Center, New York, NY, USA., Lukas RV; Department of Neurology, Northwestern University, Chicago, IL, USA., Palmer JD; The Department of Radiation Oncology, The James Cancer Hospital, Ohio State University Wexner Medical Center, Columbus, OH, USA., Suh JH; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Glas M; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, West German Cancer Center (WTZ) and German Cancer Consortium, Partner Site, Essen, Germany. |
| Source: | Journal of neuro-oncology [J Neurooncol] 2024 Aug; Vol. 169 (1), pp. 25-38. Date of Electronic Publication: 2024 Jun 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38949692 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mrugala+MM%22">Mrugala MM</searchLink>; Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix/Scottsdale, Arizona, USA. Mrugala.Maciej@mayo.edu.<br /><searchLink fieldCode="AU" term="%22Shi+W%22">Shi W</searchLink>; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Iwomoto+F%22">Iwomoto F</searchLink>; Division of Neuro-Oncology, New York-Presbyterian/Columbia University Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lukas+RV%22">Lukas RV</searchLink>; Department of Neurology, Northwestern University, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Palmer+JD%22">Palmer JD</searchLink>; The Department of Radiation Oncology, The James Cancer Hospital, Ohio State University Wexner Medical Center, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Suh+JH%22">Suh JH</searchLink>; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Glas+M%22">Glas M</searchLink>; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, University Duisburg-Essen, West German Cancer Center (WTZ) and German Cancer Consortium, Partner Site, Essen, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228309335%22">Journal of neuro-oncology</searchLink> [J Neurooncol] 2024 Aug; Vol. 169 (1), pp. 25-38. <i>Date of Electronic Publication: </i>2024 Jun 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309335 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7373 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220167594X%22">0167594X </searchLink><i>NLM ISO Abbreviation: </i>J Neurooncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38949692 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11060-024-04682-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 25 Titles: – TitleFull: Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mrugala MM – PersonEntity: Name: NameFull: Shi W – PersonEntity: Name: NameFull: Iwomoto F – PersonEntity: Name: NameFull: Lukas RV – PersonEntity: Name: NameFull: Palmer JD – PersonEntity: Name: NameFull: Suh JH – PersonEntity: Name: NameFull: Glas M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2024 Aug Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1573-7373 Numbering: – Type: volume Value: 169 – Type: issue Value: 1 Titles: – TitleFull: Journal of neuro-oncology Type: main |
| ResultId | 1 |